Similar articles

• [Oral and parenteral immunization with HIV immunosome induce the secretion of IgA specific of HIV-1 in the salivary and the production of circulatory IgA in mice and rabbits].

  Thibodeau L, Tremblay C, Lachapelle L. Thibodeau L, et al. C R Acad Sci III. 1991;313(9):389-94. C R Acad Sci III. 1991. PMID: 1756412 French.
• Evaluation of gp160 vaccinees in the hu-PBL-SCID mouse model.

  Mosier DE, Gulizia RJ, MacIsaac P, Mathieson BJ, Smith G, Hu SL, Corey L, Greenberg P. Mosier DE, et al. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1387. doi: 10.1089/aid.1992.8.1387. AIDS Res Hum Retroviruses. 1992. PMID: 1466962 No abstract available.
• HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network.

  Gorse GJ, Rogers JH, Perry JE, Newman FK, Frey SE, Patel GB, Belshe RB. Gorse GJ, et al. Vaccine. 1995 Feb;13(2):209-14. doi: 10.1016/0264-410x(95)93138-y. Vaccine. 1995. PMID: 7625118 Clinical Trial.
• Current approaches to vaccination against human immunodeficiency viruses.

  Gluckman JC, Yagello M, Bahraoui E, Girard M. Gluckman JC, et al. Allergol Immunopathol (Madr). 1991 Jan-Feb;19(1):11-3. Allergol Immunopathol (Madr). 1991. PMID: 1719790 Review. No abstract available.
• Saliva--the defender of the oral cavity.

  Amerongen AV, Veerman EC. Amerongen AV, et al. Oral Dis. 2002 Jan;8(1):12-22. doi: 10.1034/j.1601-0825.2002.1o816.x. Oral Dis. 2002. PMID: 11936451 Review. No abstract available.